human lncrna 4×180 k expression microarray (Agilent technologies)
Structured Review

Human Lncrna 4×180 K Expression Microarray, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+lncrna+4%C3%97180+k+expression+microarray/pmc04172193-81-13-15
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer"
Article Title: Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer
Journal: OncoTargets and therapy
doi: 10.2147/OTT.S68854
Figure Legend Snippet: Cluster diagram of lncRNA expression data in gastric cancer and corresponding non-tumor tissues detected by the Agilent Human LncRNA 4×180 K Expression Microarray (Agilent Technologies Inc., Santa Clara, CA, USA). Abbreviation: lncRNA, long-non-coding RNA.
Techniques Used: Expressing, Microarray
Related Articles
Labeling:Article Title: Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer Article Snippet: Tissue samples (two gastric cancer tissues and two corresponding non-cancerous tissues) and SGC7901 cells were used to synthesize double-stranded complementary DNA, which was labeled according to the protocol of the Amplification and Labeling Kit for Microarray (CapitalBio Corporation, Beijing, People’s Republic of China). .. The labeled complementary DNA was hybridized to the Agilent Human LncRNA 4×180 K Article Title: Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer Article Snippet: Tissue samples (two gastric cancer tissues and two corresponding non-cancerous tissues) and SGC7901 cells were used to synthesize double-stranded complementary DNA, which was labeled according to the protocol of the Amplification and Labeling Kit for Microarray (CapitalBio Corporation, Beijing, People’s Republic of China). .. The labeled complementary DNA was hybridized to the Agilent Human LncRNA 4×180 K Expressing:Article Title: Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer Article Snippet: Tissue samples (two gastric cancer tissues and two corresponding non-cancerous tissues) and SGC7901 cells were used to synthesize double-stranded complementary DNA, which was labeled according to the protocol of the Amplification and Labeling Kit for Microarray (CapitalBio Corporation, Beijing, People’s Republic of China). .. The labeled complementary DNA was hybridized to the Agilent Human LncRNA 4×180 K Article Title: Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer Article Snippet: .. PVT1 expression PVT1 expression levels in cancerous and adjacent noncancerous tissues from patients with gastric cancer were examined by quantitative reverse transcriptase PCR and 55 33 97 -N 55 39 40 -N 55 39 40 -T 55 33 97 -T 3210−1−3 −2 Figure 1 Cluster diagram of lncRNA expression data in gastric cancer and corresponding non-tumor tissues detected by the Agilent Human LncRNA 4×180 K Article Title: Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer Article Snippet: Tissue samples (two gastric cancer tissues and two corresponding non-cancerous tissues) and SGC7901 cells were used to synthesize double-stranded complementary DNA, which was labeled according to the protocol of the Amplification and Labeling Kit for Microarray (CapitalBio Corporation, Beijing, People’s Republic of China). .. The labeled complementary DNA was hybridized to the Agilent Human LncRNA 4×180 K Microarray:Article Title: Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer Article Snippet: Tissue samples (two gastric cancer tissues and two corresponding non-cancerous tissues) and SGC7901 cells were used to synthesize double-stranded complementary DNA, which was labeled according to the protocol of the Amplification and Labeling Kit for Microarray (CapitalBio Corporation, Beijing, People’s Republic of China). .. The labeled complementary DNA was hybridized to the Agilent Human LncRNA 4×180 K Article Title: Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer Article Snippet: .. PVT1 expression PVT1 expression levels in cancerous and adjacent noncancerous tissues from patients with gastric cancer were examined by quantitative reverse transcriptase PCR and 55 33 97 -N 55 39 40 -N 55 39 40 -T 55 33 97 -T 3210−1−3 −2 Figure 1 Cluster diagram of lncRNA expression data in gastric cancer and corresponding non-tumor tissues detected by the Agilent Human LncRNA 4×180 K Article Title: Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer Article Snippet: Tissue samples (two gastric cancer tissues and two corresponding non-cancerous tissues) and SGC7901 cells were used to synthesize double-stranded complementary DNA, which was labeled according to the protocol of the Amplification and Labeling Kit for Microarray (CapitalBio Corporation, Beijing, People’s Republic of China). .. The labeled complementary DNA was hybridized to the Agilent Human LncRNA 4×180 K Reverse Transcription:Article Title: Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer Article Snippet: .. PVT1 expression PVT1 expression levels in cancerous and adjacent noncancerous tissues from patients with gastric cancer were examined by quantitative reverse transcriptase PCR and 55 33 97 -N 55 39 40 -N 55 39 40 -T 55 33 97 -T 3210−1−3 −2 Figure 1 Cluster diagram of lncRNA expression data in gastric cancer and corresponding non-tumor tissues detected by the Agilent Human LncRNA 4×180 K Polymerase Chain Reaction:Article Title: Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer Article Snippet: .. PVT1 expression PVT1 expression levels in cancerous and adjacent noncancerous tissues from patients with gastric cancer were examined by quantitative reverse transcriptase PCR and 55 33 97 -N 55 39 40 -N 55 39 40 -T 55 33 97 -T 3210−1−3 −2 Figure 1 Cluster diagram of lncRNA expression data in gastric cancer and corresponding non-tumor tissues detected by the Agilent Human LncRNA 4×180 K |

